In this episode of the Psychedelic Spotlight podcast, we have the distinct privilege of speaking with one of the foremost experts in ketamine-assisted therapy, Dr. Steven L. Mandel, Founder and President of Ketamine Clinics Los Angeles.
Mind Cure Health’s Senior Product and Marketing Manager, Sacha Hebbert, talks about the company’s recent launch of its product sales division.
Former presidential candidate Andrew Yang wants to decriminalize psilocybin. And if he becomes mayor of New York City, that could happen.
Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression.
A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and trauma.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.